FDA Approves Extended Use of Drug Zytiga
It has been recently revealed that the FDA has approved the extended use of the drug Zytiga for men suffering from late stage of prostate cancer in which cancer keeps on increasing despite the provision of hormone therapy.
While explaining the late stage case of prostate cancer, experts affirmed that there are some tumors, which keep on growing irrespective of decline supply of testosterone. In that scenario, the drug Zytiga will be provided.
In order to test the efficacy of the drug, an experiment was carried out. The experiment included 1,088 men, who were suffering from late stage cancer. The group was randomly divided and one of the groups was provided with the drug and the other group was provided with placebo in combination with the drug known as prednisone.
It was then found that the patients in the group, which took placebo in combination with prednisone, were able to survive 30 months. However, on the other hand, patients in the group, which have taken the drug Zytiga was found to be living 35 more months.
It should be noticed that the approval has been provided under the priority review program of the FDA. Dr. Richard Pazdur, who is chief of FDA cancer drugs said, "Provides patients and health care providers the option of using Zytiga earlier in the course of treatment".
IBM is using blockchain for improving speed and security for cross-border transactions. The solution offered by IBM is focused on banking sector.
Tesla Motors has fired hundreds of employees after annual performance review. The company confirmed the move but the management hasn’t mentioned the exact number of employees fired during the current performance review.
Tesla Motors has announced recall of 11,000 Model X vehicles to fix a seat cable issue. The voluntary recall involves Model X SUVs manufactured between October 28, 2016 and August 16, 2017.
Norway is planning to add additional tax burden on consumers planning to buy electric cars.
German government has raised the growth outlook for 2017 to two percent from earlier estimate of 1.5 percent. The growth outlook for 2018 has been raised to1.9 percent from earlier estimate of 1.6 percent.
The International Monetary Fund (IMF) has raised growth outlook for global economy considering stronger growth and signs of recovery in many key markets. However, the IMF forecast has raised doubts over growth in India and the United Kingdom.